Trials / Unknown
UnknownNCT04834102
COVID-19 Induced Telogen Effluvium
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Istanbul Medeniyet University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection
Detailed description
Telogen effluvium (TE) is one of the most common causes of non-scarring alopecia. During the COVİD-19 pandemic, there is an increased number of Telogen effluvium patients.This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection and correlation between the severity of covid-19 and TE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood Tests | Evaluation of blood ferritin, hemoglobine, serum iron and serum iron binding capacity |
Timeline
- Start date
- 2021-01-27
- Primary completion
- 2021-04-27
- Completion
- 2021-04-27
- First posted
- 2021-04-06
- Last updated
- 2021-04-06
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04834102. Inclusion in this directory is not an endorsement.